Global Human Recombinant Insulin Sales Market Report 2021

Publisher Name :
Date: 06-May-2021
No. of pages: 143
Inquire Before Buying

The global Human Recombinant Insulin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Recombinant Insulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- Rapid-Acting Human Insulin

- Regular (Short Acting) Insulin

- NPH (Intermediate Acting) Insulin

- Long-Acting Human Insulin

- Premixed Human Insulins Insulin

Segment by Application

- Hospital

- Retail Pharmacy

- Online Pharmacies

- Other

The Human Recombinant Insulin market is analysed and market size information is provided by regions (countries). Segment by Application, the Human Recombinant Insulin market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- Novo Nordisk

- Eli Lilly and Company

- Sanofi

- Julphar Gulf Pharmaceutical Industries

- Bioton

- Gan & Lee Pharmaceuticals

- Zhuhai United Laboratories

- Biocon

- Wanbang Biopharmaceuticals

- Dongbao Enterprise Group

- PeproTech

Global Human Recombinant Insulin Sales Market Report 2021

Table of Contents
1 Human Recombinant Insulin Market Overview
1.1 Human Recombinant Insulin Product Scope
1.2 Human Recombinant Insulin Segment by Type
1.2.1 Global Human Recombinant Insulin Sales by Type (2016 & 2021 & 2027)
1.2.2 Rapid-Acting Human Insulin
1.2.3 Regular (Short Acting) Insulin
1.2.4 NPH (Intermediate Acting) Insulin
1.2.5 Long-Acting Human Insulin
1.2.6 Premixed Human Insulins Insulin
1.3 Human Recombinant Insulin Segment by Application
1.3.1 Global Human Recombinant Insulin Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacies
1.3.5 Other
1.4 Human Recombinant Insulin Market Estimates and Forecasts (2016-2027)
1.4.1 Global Human Recombinant Insulin Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Human Recombinant Insulin Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Human Recombinant Insulin Price Trends (2016-2027)
2 Human Recombinant Insulin Estimates and Forecasts by Region
2.1 Global Human Recombinant Insulin Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Human Recombinant Insulin Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Human Recombinant Insulin Sales Market Share by Region (2016-2021)
2.2.2 Global Human Recombinant Insulin Revenue Market Share by Region (2016-2021)
2.3 Global Human Recombinant Insulin Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Human Recombinant Insulin Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Human Recombinant Insulin Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Human Recombinant Insulin Estimates and Projections (2016-2027)
2.4.2 Europe Human Recombinant Insulin Estimates and Projections (2016-2027)
2.4.3 China Human Recombinant Insulin Estimates and Projections (2016-2027)
2.4.4 Japan Human Recombinant Insulin Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Human Recombinant Insulin Estimates and Projections (2016-2027)
2.4.6 India Human Recombinant Insulin Estimates and Projections (2016-2027)
3 Global Human Recombinant Insulin Competition Landscape by Players
3.1 Global Top Human Recombinant Insulin Players by Sales (2016-2021)
3.2 Global Top Human Recombinant Insulin Players by Revenue (2016-2021)
3.3 Global Human Recombinant Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Recombinant Insulin as of 2020)
3.4 Global Human Recombinant Insulin Average Price by Company (2016-2021)
3.5 Manufacturers Human Recombinant Insulin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Human Recombinant Insulin Market Size by Type
4.1 Global Human Recombinant Insulin Historic Market Review by Type (2016-2021)
4.1.1 Global Human Recombinant Insulin Sales Market Share by Type (2016-2021)
4.1.2 Global Human Recombinant Insulin Revenue Market Share by Type (2016-2021)
4.1.3 Global Human Recombinant Insulin Price by Type (2016-2021)
4.2 Global Human Recombinant Insulin Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Human Recombinant Insulin Sales Forecast by Type (2022-2027)
4.2.2 Global Human Recombinant Insulin Revenue Forecast by Type (2022-2027)
4.2.3 Global Human Recombinant Insulin Price Forecast by Type (2022-2027)
5 Global Human Recombinant Insulin Market Size by Application
5.1 Global Human Recombinant Insulin Historic Market Review by Application (2016-2021)
5.1.1 Global Human Recombinant Insulin Sales Market Share by Application (2016-2021)
5.1.2 Global Human Recombinant Insulin Revenue Market Share by Application (2016-2021)
5.1.3 Global Human Recombinant Insulin Price by Application (2016-2021)
5.2 Global Human Recombinant Insulin Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Human Recombinant Insulin Sales Forecast by Application (2022-2027)
5.2.2 Global Human Recombinant Insulin Revenue Forecast by Application (2022-2027)
5.2.3 Global Human Recombinant Insulin Price Forecast by Application (2022-2027)
6 North America Human Recombinant Insulin Market Facts & Figures
6.1 North America Human Recombinant Insulin Sales by Company
6.1.1 North America Human Recombinant Insulin Sales by Company (2016-2021)
6.1.2 North America Human Recombinant Insulin Revenue by Company (2016-2021)
6.2 North America Human Recombinant Insulin Sales Breakdown by Type
6.2.1 North America Human Recombinant Insulin Sales Breakdown by Type (2016-2021)
6.2.2 North America Human Recombinant Insulin Sales Breakdown by Type (2022-2027)
6.3 North America Human Recombinant Insulin Sales Breakdown by Application
6.3.1 North America Human Recombinant Insulin Sales Breakdown by Application (2016-2021)
6.3.2 North America Human Recombinant Insulin Sales Breakdown by Application (2022-2027)
7 Europe Human Recombinant Insulin Market Facts & Figures
7.1 Europe Human Recombinant Insulin Sales by Company
7.1.1 Europe Human Recombinant Insulin Sales by Company (2016-2021)
7.1.2 Europe Human Recombinant Insulin Revenue by Company (2016-2021)
7.2 Europe Human Recombinant Insulin Sales Breakdown by Type
7.2.1 Europe Human Recombinant Insulin Sales Breakdown by Type (2016-2021)
7.2.2 Europe Human Recombinant Insulin Sales Breakdown by Type (2022-2027)
7.3 Europe Human Recombinant Insulin Sales Breakdown by Application
7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)
8 China Human Recombinant Insulin Market Facts & Figures
8.1 China Human Recombinant Insulin Sales by Company
8.1.1 China Human Recombinant Insulin Sales by Company (2016-2021)
8.1.2 China Human Recombinant Insulin Revenue by Company (2016-2021)
8.2 China Human Recombinant Insulin Sales Breakdown by Type
8.2.1 China Human Recombinant Insulin Sales Breakdown by Type (2016-2021)
8.2.2 China Human Recombinant Insulin Sales Breakdown by Type (2022-2027)
8.3 China Human Recombinant Insulin Sales Breakdown by Application
8.3.1 China 311 Sales Breakdown by Application (2016-2021)
8.3.2 China 311 Sales Breakdown by Application (2022-2027)
9 Japan Human Recombinant Insulin Market Facts & Figures
9.1 Japan Human Recombinant Insulin Sales by Company
9.1.1 Japan Human Recombinant Insulin Sales by Company (2016-2021)
9.1.2 Japan Human Recombinant Insulin Revenue by Company (2016-2021)
9.2 Japan Human Recombinant Insulin Sales Breakdown by Type
9.2.1 Japan Human Recombinant Insulin Sales Breakdown by Type (2016-2021)
9.2.2 Japan Human Recombinant Insulin Sales Breakdown by Type (2022-2027)
9.3 Japan Human Recombinant Insulin Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Human Recombinant Insulin Market Facts & Figures
10.1 Southeast Asia Human Recombinant Insulin Sales by Company
10.1.1 Southeast Asia Human Recombinant Insulin Sales by Company (2016-2021)
10.1.2 Southeast Asia Human Recombinant Insulin Revenue by Company (2016-2021)
10.2 Southeast Asia Human Recombinant Insulin Sales Breakdown by Type
10.2.1 Southeast Asia Human Recombinant Insulin Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Human Recombinant Insulin Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Human Recombinant Insulin Sales Breakdown by Application
10.3.1 Southeast Asia K Litre Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Litre Sales Breakdown by Application (2022-2027)
11 India Human Recombinant Insulin Market Facts & Figures
11.1 India Human Recombinant Insulin Sales by Company
11.1.1 India Human Recombinant Insulin Sales by Company (2016-2021)
11.1.2 India Human Recombinant Insulin Revenue by Company (2016-2021)
11.2 India Human Recombinant Insulin Sales Breakdown by Type
11.2.1 India Human Recombinant Insulin Sales Breakdown by Type (2016-2021)
11.2.2 India Human Recombinant Insulin Sales Breakdown by Type (2022-2027)
11.3 India Human Recombinant Insulin Sales Breakdown by Application
11.3.1 India Human Recombinant Insulin Sales Breakdown by Application (2016-2021)
11.3.2 India Human Recombinant Insulin Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Human Recombinant Insulin Business
12.1 Novo Nordisk
12.1.1 Novo Nordisk Corporation Information
12.1.2 Novo Nordisk Business Overview
12.1.3 Novo Nordisk Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novo Nordisk Human Recombinant Insulin Products Offered
12.1.5 Novo Nordisk Recent Development
12.2 Eli Lilly and Company
12.2.1 Eli Lilly and Company Corporation Information
12.2.2 Eli Lilly and Company Business Overview
12.2.3 Eli Lilly and Company Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Eli Lilly and Company Human Recombinant Insulin Products Offered
12.2.5 Eli Lilly and Company Recent Development
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Business Overview
12.3.3 Sanofi Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Human Recombinant Insulin Products Offered
12.3.5 Sanofi Recent Development
12.4 Julphar Gulf Pharmaceutical Industries
12.4.1 Julphar Gulf Pharmaceutical Industries Corporation Information
12.4.2 Julphar Gulf Pharmaceutical Industries Business Overview
12.4.3 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Products Offered
12.4.5 Julphar Gulf Pharmaceutical Industries Recent Development
12.5 Bioton
12.5.1 Bioton Corporation Information
12.5.2 Bioton Business Overview
12.5.3 Bioton Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bioton Human Recombinant Insulin Products Offered
12.5.5 Bioton Recent Development
12.6 Gan & Lee Pharmaceuticals
12.6.1 Gan & Lee Pharmaceuticals Corporation Information
12.6.2 Gan & Lee Pharmaceuticals Business Overview
12.6.3 Gan & Lee Pharmaceuticals Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Gan & Lee Pharmaceuticals Human Recombinant Insulin Products Offered
12.6.5 Gan & Lee Pharmaceuticals Recent Development
12.7 Zhuhai United Laboratories
12.7.1 Zhuhai United Laboratories Corporation Information
12.7.2 Zhuhai United Laboratories Business Overview
12.7.3 Zhuhai United Laboratories Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Zhuhai United Laboratories Human Recombinant Insulin Products Offered
12.7.5 Zhuhai United Laboratories Recent Development
12.8 Biocon
12.8.1 Biocon Corporation Information
12.8.2 Biocon Business Overview
12.8.3 Biocon Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Biocon Human Recombinant Insulin Products Offered
12.8.5 Biocon Recent Development
12.9 Wanbang Biopharmaceuticals
12.9.1 Wanbang Biopharmaceuticals Corporation Information
12.9.2 Wanbang Biopharmaceuticals Business Overview
12.9.3 Wanbang Biopharmaceuticals Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Wanbang Biopharmaceuticals Human Recombinant Insulin Products Offered
12.9.5 Wanbang Biopharmaceuticals Recent Development
12.10 Dongbao Enterprise Group
12.10.1 Dongbao Enterprise Group Corporation Information
12.10.2 Dongbao Enterprise Group Business Overview
12.10.3 Dongbao Enterprise Group Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Dongbao Enterprise Group Human Recombinant Insulin Products Offered
12.10.5 Dongbao Enterprise Group Recent Development
12.11 PeproTech
12.11.1 PeproTech Corporation Information
12.11.2 PeproTech Business Overview
12.11.3 PeproTech Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 PeproTech Human Recombinant Insulin Products Offered
12.11.5 PeproTech Recent Development
13 Human Recombinant Insulin Manufacturing Cost Analysis
13.1 Human Recombinant Insulin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Recombinant Insulin
13.4 Human Recombinant Insulin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Recombinant Insulin Distributors List
14.3 Human Recombinant Insulin Customers
15 Market Dynamics
15.1 Human Recombinant Insulin Market Trends
15.2 Human Recombinant Insulin Drivers
15.3 Human Recombinant Insulin Market Challenges
15.4 Human Recombinant Insulin Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Human Recombinant Insulin Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Human Recombinant Insulin Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Human Recombinant Insulin Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Human Recombinant Insulin Sales (K Litre) by Region (2016-2021)
Table 5. Global Human Recombinant Insulin Sales Market Share by Region (2016-2021)
Table 6. Global Human Recombinant Insulin Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Human Recombinant Insulin Revenue Share by Region (2016-2021)
Table 8. Global Human Recombinant Insulin Sales (K Litre) Forecast by Region (2022-2027)
Table 9. Global Human Recombinant Insulin Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Human Recombinant Insulin Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Human Recombinant Insulin Revenue Share Forecast by Region (2022-2027)
Table 12. Global Human Recombinant Insulin Sales (K Litre) of Key Companies (2016-2021)
Table 13. Global Human Recombinant Insulin Sales Share by Company (2016-2021)
Table 14. Global Human Recombinant Insulin Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Human Recombinant Insulin Revenue Share by Company (2016-2021)
Table 16. Global Human Recombinant Insulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Recombinant Insulin as of 2020)
Table 17. Global Human Recombinant Insulin Average Price (USD/Litre) of Key Company (2016-2021)
Table 18. Manufacturers Human Recombinant Insulin Manufacturing Sites and Area Served
Table 19. Manufacturers Human Recombinant Insulin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Human Recombinant Insulin Sales (K Litre) by Type (2016-2021)
Table 22. Global Human Recombinant Insulin Sales Share by Type (2016-2021)
Table 23. Global Human Recombinant Insulin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Human Recombinant Insulin Price (USD/Litre) by Type (2016-2021)
Table 25. Global Human Recombinant Insulin Sales Share by Type (2022-2027)
Table 26. Global Human Recombinant Insulin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Human Recombinant Insulin Revenue Share by Type (2022-2027)
Table 28. Global Human Recombinant Insulin Price (USD/Litre) by Type (2022-2027)
Table 29. Global Human Recombinant Insulin Sales (K Litre) by Application (2016-2021)
Table 30. Global Human Recombinant Insulin Sales Share by Application (2016-2021)
Table 31. Global Human Recombinant Insulin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Human Recombinant Insulin Price (USD/Litre) by Application (2016-2021)
Table 33. Global Human Recombinant Insulin Sales (K Litre) by Application (2022-2027)
Table 34. Global Human Recombinant Insulin Sales Share by Application (2022-2027)
Table 35. Global Human Recombinant Insulin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Human Recombinant Insulin Revenue Share by Application (2022-2027)
Table 37. Global Human Recombinant Insulin Price (USD/Litre) by Application (2022-2027)
Table 38. North America Human Recombinant Insulin Sales (K Litre) by Company (2016-2021)
Table 39. North America Human Recombinant Insulin Sales Market Share by Company (2016-2021)
Table 40. North America Human Recombinant Insulin Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Human Recombinant Insulin Revenue Market Share by Company (2016-2021)
Table 42. North America Human Recombinant Insulin Sales by Type (2016-2021) & (K Litre)
Table 43. North America Human Recombinant Insulin Sales Market Share by Type (2016-2021)
Table 44. North America Human Recombinant Insulin Sales by Type (2022-2027) & (K Litre)
Table 45. North America Human Recombinant Insulin Sales Market Share by Type (2022-2027)
Table 46. North America Human Recombinant Insulin Sales by Application (2016-2021) & (K Litre)
Table 47. North America Human Recombinant Insulin Sales Market Share by Application (2016-2021)
Table 48. North America Human Recombinant Insulin Sales by Application (2022-2027) & (K Litre)
Table 49. North America Human Recombinant Insulin Sales Market Share by Application (2022-2027)
Table 50. Europe Human Recombinant Insulin Sales (K Litre) by Company (2016-2021)
Table 51. Europe Human Recombinant Insulin Sales Market Share by Company (2016-2021)
Table 52. Europe Human Recombinant Insulin Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Human Recombinant Insulin Revenue Market Share by Company (2016-2021)
Table 54. Europe Human Recombinant Insulin Sales by Type (2016-2021) & (K Litre)
Table 55. Europe Human Recombinant Insulin Sales Market Share by Type (2016-2021)
Table 56. Europe Human Recombinant Insulin Sales by Type (2022-2027) & (K Litre)
Table 57. Europe Human Recombinant Insulin Sales Market Share by Type (2022-2027)
Table 58. Europe Human Recombinant Insulin Sales by Application (2016-2021) & (K Litre)
Table 59. Europe Human Recombinant Insulin Sales Market Share by Application (2016-2021)
Table 60. Europe Human Recombinant Insulin Sales by Application (2022-2027) & (K Litre)
Table 61. Europe Human Recombinant Insulin Sales Market Share by Application (2022-2027)
Table 62. China Human Recombinant Insulin Sales (K Litre) by Company (2016-2021)
Table 63. China Human Recombinant Insulin Sales Market Share by Company (2016-2021)
Table 64. China Human Recombinant Insulin Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Human Recombinant Insulin Revenue Market Share by Company (2016-2021)
Table 66. China Human Recombinant Insulin Sales by Type (2016-2021) & (K Litre)
Table 67. China Human Recombinant Insulin Sales Market Share by Type (2016-2021)
Table 68. China Human Recombinant Insulin Sales by Type (2022-2027) & (K Litre)
Table 69. China Human Recombinant Insulin Sales Market Share by Type (2022-2027)
Table 70. China Human Recombinant Insulin Sales by Application (2016-2021) & (K Litre)
Table 71. China Human Recombinant Insulin Sales Market Share by Application (2016-2021)
Table 72. China Human Recombinant Insulin Sales by Application (2022-2027) & (K Litre)
Table 73. China Human Recombinant Insulin Sales Market Share by Application (2022-2027)
Table 74. Japan Human Recombinant Insulin Sales (K Litre) by Company (2016-2021)
Table 75. Japan Human Recombinant Insulin Sales Market Share by Company (2016-2021)
Table 76. Japan Human Recombinant Insulin Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Human Recombinant Insulin Revenue Market Share by Company (2016-2021)
Table 78. Japan Human Recombinant Insulin Sales by Type (2016-2021) & (K Litre)
Table 79. Japan Human Recombinant Insulin Sales Market Share by Type (2016-2021)
Table 80. Japan Human Recombinant Insulin Sales by Type (2022-2027) & (K Litre)
Table 81. Japan Human Recombinant Insulin Sales Market Share by Type (2022-2027)
Table 82. Japan Human Recombinant Insulin Sales by Application (2016-2021) & (K Litre)
Table 83. Japan Human Recombinant Insulin Sales Market Share by Application (2016-2021)
Table 84. Japan Human Recombinant Insulin Sales by Application (2022-2027) & (K Litre)
Table 85. Japan Human Recombinant Insulin Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Human Recombinant Insulin Sales (K Litre) by Company (2016-2021)
Table 87. Southeast Asia Human Recombinant Insulin Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Human Recombinant Insulin Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Human Recombinant Insulin Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Human Recombinant Insulin Sales by Type (2016-2021) & (K Litre)
Table 91. Southeast Asia Human Recombinant Insulin Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Human Recombinant Insulin Sales by Type (2022-2027) & (K Litre)
Table 93. Southeast Asia Human Recombinant Insulin Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Human Recombinant Insulin Sales by Application (2016-2021) & (K Litre)
Table 95. Southeast Asia Human Recombinant Insulin Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Human Recombinant Insulin Sales by Application (2022-2027) & (K Litre)
Table 97. Southeast Asia Human Recombinant Insulin Sales Market Share by Application (2022-2027)
Table 98. India Human Recombinant Insulin Sales (K Litre) by Company (2016-2021)
Table 99. India Human Recombinant Insulin Sales Market Share by Company (2016-2021)
Table 100. India Human Recombinant Insulin Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Human Recombinant Insulin Revenue Market Share by Company (2016-2021)
Table 102. India Human Recombinant Insulin Sales by Type (2016-2021) & (K Litre)
Table 103. India Human Recombinant Insulin Sales Market Share by Type (2016-2021)
Table 104. India Human Recombinant Insulin Sales by Type (2022-2027) & (K Litre)
Table 105. India Human Recombinant Insulin Sales Market Share by Type (2022-2027)
Table 106. India Human Recombinant Insulin Sales by Application (2016-2021) & (K Litre)
Table 107. India Human Recombinant Insulin Sales Market Share by Application (2016-2021)
Table 108. India Human Recombinant Insulin Sales by Application (2022-2027) & (K Litre)
Table 109. India Human Recombinant Insulin Sales Market Share by Application (2022-2027)
Table 110. Novo Nordisk Corporation Information
Table 111. Novo Nordisk Description and Business Overview
Table 112. Novo Nordisk Human Recombinant Insulin Sales (K Litre), Revenue (Million USD), Price (USD/Litre) and Gross Margin (2016-2021)
Table 113. Novo Nordisk Human Recombinant Insulin Product
Table 114. Novo Nordisk Recent Development
Table 115. Eli Lilly and Company Corporation Information
Table 116. Eli Lilly and Company Description and Business Overview
Table 117. Eli Lilly and Company Human Recombinant Insulin Sales (K Litre), Revenue (Million USD), Price (USD/Litre) and Gross Margin (2016-2021)
Table 118. Eli Lilly and Company Human Recombinant Insulin Product
Table 119. Eli Lilly and Company Recent Development
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Business Overview
Table 122. Sanofi Human Recombinant Insulin Sales (K Litre), Revenue (Million USD), Price (USD/Litre) and Gross Margin (2016-2021)
Table 123. Sanofi Human Recombinant Insulin Product
Table 124. Sanofi Recent Development
Table 125. Julphar Gulf Pharmaceutical Industries Corporation Information
Table 126. Julphar Gulf Pharmaceutical Industries Description and Business Overview
Table 127. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Sales (K Litre), Revenue (Million USD), Price (USD/Litre) and Gross Margin (2016-2021)
Table 128. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Product
Table 129. Julphar Gulf Pharmaceutical Industries Recent Development
Table 130. Bioton Corporation Information
Table 131. Bioton Description and Business Overview
Table 132. Bioton Human Recombinant Insulin Sales (K Litre), Revenue (Million USD), Price (USD/Litre) and Gross Margin (2016-2021)
Table 133. Bioton Human Recombinant Insulin Product
Table 134. Bioton Recent Development
Table 135. Gan & Lee Pharmaceuticals Corporation Information
Table 136. Gan & Lee Pharmaceuticals Description and Business Overview
Table 137. Gan & Lee Pharmaceuticals Human Recombinant Insulin Sales (K Litre), Revenue (Million USD), Price (USD/Litre) and Gross Margin (2016-2021)
Table 138. Gan & Lee Pharmaceuticals Human Recombinant Insulin Product
Table 139. Gan & Lee Pharmaceuticals Recent Development
Table 140. Zhuhai United Laboratories Corporation Information
Table 141. Zhuhai United Laboratories Description and Business Overview
Table 142. Zhuhai United Laboratories Human Recombinant Insulin Sales (K Litre), Revenue (Million USD), Price (USD/Litre) and Gross Margin (2016-2021)
Table 143. Zhuhai United Laboratories Human Recombinant Insulin Product
Table 144. Zhuhai United Laboratories Recent Development
Table 145. Biocon Corporation Information
Table 146. Biocon Human Recombinant Insulin Sales (K Litre), Revenue (Million USD), Price (USD/Litre) and Gross Margin (2016-2021)
Table 147. Biocon Description and Business Overview
Table 148. Biocon Human Recombinant Insulin Product
Table 149. Biocon Recent Development
Table 150. Wanbang Biopharmaceuticals Corporation Information
Table 151. Wanbang Biopharmaceuticals Human Recombinant Insulin Sales (K Litre), Revenue (Million USD), Price (USD/Litre) and Gross Margin (2016-2021)
Table 152. Wanbang Biopharmaceuticals Description and Business Overview
Table 153. Wanbang Biopharmaceuticals Human Recombinant Insulin Product
Table 154. Wanbang Biopharmaceuticals Recent Development
Table 155. Dongbao Enterprise Group Corporation Information
Table 156. Dongbao Enterprise Group Description and Business Overview
Table 157. Dongbao Enterprise Group Human Recombinant Insulin Sales (K Litre), Revenue (Million USD), Price (USD/Litre) and Gross Margin (2016-2021)
Table 158. Dongbao Enterprise Group Human Recombinant Insulin Product
Table 159. Dongbao Enterprise Group Recent Development
Table 160. PeproTech Corporation Information
Table 161. PeproTech Description and Business Overview
Table 162. PeproTech Human Recombinant Insulin Sales (K Litre), Revenue (Million USD), Price (USD/Litre) and Gross Margin (2016-2021)
Table 163. PeproTech Human Recombinant Insulin Product
Table 164. PeproTech Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Human Recombinant Insulin Distributors List
Table 168. Human Recombinant Insulin Customers List
Table 169. Human Recombinant Insulin Market Trends
Table 170. Human Recombinant Insulin Market Drivers
Table 171. Human Recombinant Insulin Market Challenges
Table 172. Human Recombinant Insulin Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Recombinant Insulin Product Picture
Figure 2. Global Human Recombinant Insulin Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Human Recombinant Insulin Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Examples
Figure 7. Retail Pharmacy Examples
Figure 8. Online Pharmacies Examples
Figure 9. Other Examples
Figure 10. Global Human Recombinant Insulin Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Human Recombinant Insulin Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Human Recombinant Insulin Sales (K Litre) Growth Rate (2016-2027)
Figure 13. Global Human Recombinant Insulin Price Trends Growth Rate (2016-2027) (USD/Litre)
Figure 14. Global Human Recombinant Insulin Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Human Recombinant Insulin Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Human Recombinant Insulin Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Human Recombinant Insulin Sales (K Litre) Growth Rate (2016-2027)
Figure 18. Europe Human Recombinant Insulin Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Human Recombinant Insulin Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Human Recombinant Insulin Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Human Recombinant Insulin Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Human Recombinant Insulin Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Human Recombinant Insulin Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Human Recombinant Insulin Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Human Recombinant Insulin Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Human Recombinant Insulin Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Human Recombinant Insulin Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Human Recombinant Insulin Players Market Share by Revenue in Human Recombinant Insulin: 2016 & 2020
Figure 29. Human Recombinant Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Human Recombinant Insulin Revenue Share by Type (2016-2021)
Figure 31. Global Human Recombinant Insulin Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Human Recombinant Insulin Revenue Share by Application (2016-2021)
Figure 33. Global Human Recombinant Insulin Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Human Recombinant Insulin Sales Market Share by Type in 2020
Figure 35. North America Human Recombinant Insulin Sales Market Share by Application in 2020
Figure 36. Europe Human Recombinant Insulin Sales Market Share by Type in 2020
Figure 37. Europe Human Recombinant Insulin Sales Market Share by Application in 2020
Figure 38. China H
  • Global Prenatal Vitamin Ingredients Sales Market Report 2021
    Published: 11-Jun-2021        Price: US 4000 Onwards        Pages: 146
    Market Analysis and Insights: Global Prenatal Vitamin Ingredients Market The global Prenatal Vitamin Ingredients market was valued at US$ 51370 in 2020 and will reach US$ 63150 million by the end of 2027, growing at a CAGR of 3.5% during 2022-2027. Global Prenatal Vitamin Ingredients Scope and Market Size The global Prenatal Vitamin Ingredients market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants......
  • Global Specialty Supplements Sales Market Report 2021
    Published: 11-Jun-2021        Price: US 4000 Onwards        Pages: 144
    A specialty supplement is a formula that has been specially designed to support a specific structure/function application in the body - such as joint health and immune support. Some are single-ingredient products. Others are combination formulas, providing unique blends of complementary ingredients that scientific research has shown work synergistically in the body to illicit similar pharmacological effects. Market Analysis and Insights: Global Specialty Supplements Market ......
  • Global Letter Vitamins Sales Market Report 2021
    Published: 11-Jun-2021        Price: US 4000 Onwards        Pages: 148
    A vitamin is an organic molecule (or related set of molecules) that is an essential micronutrient that an organism needs in small quantities for the proper functioning of its metabolism. Essential nutrients cannot be synthesized in the organism, either at all or not in sufficient quantities, and therefore must be obtained through the diet. Vitamin C can be synthesized by some species but not by others; it is not a vitamin in the first instance but is in the second. Market Analysis......
  • Global Curcuminoid Sales Market Report 2021
    Published: 11-Jun-2021        Price: US 4000 Onwards        Pages: 142
    Market Analysis and Insights: Global Curcuminoid Market The global Curcuminoid market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Curcuminoid Scope and Market Size The global Curcuminoid market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Curcuminoid market will be able to gain the upper hand as th......
  • Global Pet Medicine Sales Market Report 2021
    Published: 11-Jun-2021        Price: US 4000 Onwards        Pages: 136
    Well over half of the triplicate in the United States own a pet -- almost 80 million homes!Man 's best friend took a be the most iconic. But it' s been a dog, cat, horse, bird, fish, or lizard, pets need to be cared for, pet medical is required. Market Analysis and Insights: Global Pet Medicine Market The global Pet Medicine market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global ......
  • Global Large Volume Parenteral (LVP) Market Insights and Forecast to 2027
    Published: 11-Jun-2021        Price: US 4900 Onwards        Pages: 148
    Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be adm......
  • Global Seaweed Powder Market Insights and Forecast to 2027
    Published: 11-Jun-2021        Price: US 4900 Onwards        Pages: 118
    Seaweed powder is made from marine natural seaweed, supplemented by a small amount of marine microalgae. Natural seaweed powder is rich in seaweed polysaccharides, mannitol, amino acids, proteins, vitamins and potassium, iron, calcium, phosphorus, iodine, selenium, cobalt and other trace elements. The global seaweed powder market is dominated by the Asia Pacific region, and North America is the second largest regional market. At present, the main manufacturers of seaweed powder are ......
  • Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Insights and Forecast to 2027
    Published: 11-Jun-2021        Price: US 4900 Onwards        Pages: 111
    Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. The classification of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs includes 5-HT3 Inhibitors, NK1 Inhibitors and others. The proportion of 5-HT3 Inhibitors in 2017 is about 62%, and the proportion of NK1 Inhibitors in 2017 is about 33%. Market A......
  • Global Cell Culture Protein Surface Coatings Market Insights and Forecast to 2027
    Published: 11-Jun-2021        Price: US 4900 Onwards        Pages: 115
    The cell culture protein surface coating is a technique in which the cell culture surfaces are coated with extracellular matrix or proteins components to improve the proliferation and adhesion of the cells in vitro. In the last several years, global market of Cell Culture Protein Surface Coatings developed rapidly, with an average growth rate of 13.7%. Market Analysis and Insights: Global Cell Culture Protein Surface Coatings Market The global Cell Culture Protein Su......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs